Institute of Biomedical Research Corp.
Institute of Biomedical Research Corp. (MRES) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
mres · pe ratio · data through Mar 31, 2025
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for Institute of Biomedical Research Corp. (MRES) measures how much investors pay for each dollar of the company's trailing earnings. MRES's current PE ratio of N/A is calculated by dividing its stock price of $0.00 by its TTM earnings per share of -$0.00.
Source: FMP · /ratios-ttm · /analyst-estimates · 2025-03-31
PE Ratio History
2003 – 2025 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
PE Ratio vs Peers
Biotechnology · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Institute of Biomedical Research Corp.You MRES | $4M | N/A | — | -$0.00 |
 Bonus BioGroup Ltd. BBIXF | $152M | N/A | — | -$0.04 |
 INDVR Brands Inc. CAAOF | $0M | N/A | — | -$0.06 |
 Choom Holdings Inc. CHOOF | $0M | N/A | — | -$0.07 |
 Celyad Oncology S.A. CLYYF | $11M | 6.58x | — | $0.02 |
 EvoNext Holdings S.A. ELVAF | $8M | N/A | — | -$0.09 |
 Finch Therapeutics Group, Inc. FNCH | $12M | N/A | — | -$8.64 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2025-03-31Latest FY2025 | — | $-0.00 | — | |
2024-03-31 FY2024 | 15.87x | $0.00 | — | |
2023-03-31 FY2023 | — | $-0.00 | — | |
2022-03-31 FY2022 | — | $-0.00 | — | |
2021-03-31 FY2021 | — | $-0.00 | — | |
2010-03-31 FY2010 | — | $-0.05 | — | |
2009-03-31 FY2009 | — | $-0.09 | — | |
2008-03-31 FY2008 | — | $-1.88 | — | |
2007-03-31 FY2007 | — | $-0.39 | — | |
2006-03-31 FY2006 | — | $-0.13 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Institute of Biomedical Research Corp. (MRES) measures how much investors pay for each dollar of the company's trailing earnings. MRES's current PE ratio of N/A is calculated by dividing its stock price of $0.00 by its TTM earnings per share of -$0.00.
Frequently asked questions
MRES pe ratio · 6 questionsMRES's current PE ratio is N/A as of 2026-06-09, based on a stock price of $0.00 and TTM EPS of -$0.00. Data sourced from Financial Modeling Prep via MRES's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Institute of Biomedical Research Corp. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09